Abstract
Chronic opioid therapy, and specifically its access, has undergone dramatic swings over the last 30 years, with little focus on the data until recently. There is a clear focus on minimizing opioid initiation and employing opioid mitigating treatments. In this chapter, we review the current guideline statements regarding safe prescribing and discuss their role on the non-cancer-related patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
Han B, Compton W, et al. Non-medical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314(4):1468–78.
https://www.cdc.gov/drugoverdose/pdf/guidelines_at-a-glance-a.pdf.
https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htmNNT versus NNH.
Levy RM. Neuromodulation: the “not-so-hidden” cure for the opioid crisis. Neuromodulation. 2017;20:519–24.
Sharan AD, Riley J, Falowski S, Pope JE, et al. Association of opioid usage with spinal cord stimulation outcomes. Pain Med. 2017;0:1–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pope, J.E., Deer, T.R. (2019). Opioids for Chronic Non-cancer Pain. In: Deer, T., Pope, J., Lamer, T., Provenzano, D. (eds) Deer's Treatment of Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-12281-2_28
Download citation
DOI: https://doi.org/10.1007/978-3-030-12281-2_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12280-5
Online ISBN: 978-3-030-12281-2
eBook Packages: MedicineMedicine (R0)